For over three decades, HIV has played an elaborate game of hide-and-seek with researchers, making treating—and possibly even ...

A groundbreaking discovery reveals how HIV integrates its genetic material into human DNA, exposing a key viral vulnerability ...

HIV cases and deaths are rising in Bangladesh. Find out why HIV is dangerous, how it spreads, and what India can do to ...

Research published in The Lancet HIV earlier this year, experts estimated that, if purchased at scale, the cost of generic lenacapavir could range from USD 35 to USD 46 per person-year. Falling to USD ...

HIV/AIDS remains a major public health threat worldwide, with an estimated 39.9 million people living with the disease at the end of 2023. Around 630,000 people died from illnesses related to AIDS the ...

San Francisco reported a small uptick in new HIV diagnoses in 2024, a disappointing finding in its annual HIV/AIDS report ...

Scientists say the drug stops the virus from replicating inside cells. The landmark deal to provide cheaper antiretroviral ...

Yeztugo (lenacapavir) is an HIV-1 capsid inhibitor that is administered every 6 months after an initial dosing regimen.

Lots of scholarship assumes that partners in higher-quality relationships work together to reduce health-related risks. A new study tested this assumption.

Cuts proposed by the Trump administration and House Republicans could drive up new HIV cases by more than 200,000 by 2030, ...

The South Carolina Department of Public Health (DPH) is observing its sixth annual PrEP (pre-exposure prophylaxis) Awareness ...

Donald Trump claimed there’s “no reason” to vaccinate a baby against hepatitis B, a highly contagious disease that can spread ...